carlyle is a global investment firm with $325 billion of assets under management. our purpose is to invest wisely and create value on behalf of our investors, portfolio companies and the communities in which we live and invest. founded in 1987 in washington, dc, carlyle has grown into one of the world’s largest and most successful global investment firms, with nearly 1,850 people operating in 26 offices across five continents.
Company profile
Ticker
CG, CG-MM
Exchange
Website
CEO
William E. Conway, Jr.
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Carlyle Group L.P.
SEC CIK
Corporate docs
Subsidiaries
Abingworth Bioventures 8 GP LP • Abingworth Bioventures GP Limited • Abingworth Bioventures V GP limited • Abingworth CCD GP Limited • Abingworth Clinical Co-Development Fund 2 GP LP • Abingworth German Designated LP Corp. • Abingworth Management Inc • Abingworth Second Partner Limited • ACP 2021 Agg. GP, LLC • ACP 2022 Agg. GP, LLC ...
IRS number
452832612
SEC advisor number
801-52462
FINRA CRD number
111128
AUM ?
$143.79 bn
(as of 29 Mar 20)
Accounts
561
(as of 29 Mar 20)
Employees
864
(286 investment advisory or research)
Address
Carlyle Group Inc
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON
DC 20004
C/O THE CARLYLE GROUP
1001 PENNSYLVANIA AVENUE, N.W.
WASHINGTON
DC 20004
Phone
202 729 5626
CG stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
18 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 24
DEF 14A
Definitive proxy
18 Apr 24
PRE 14A
Preliminary proxy
3 Apr 24
8-K
Carlyle Appoints Afsaneh M. Beschloss as an Independent Director
3 Apr 24
8-K
Carlyle Names Lindsay LoBue as Chief Operating Officer
27 Mar 24
8-K
Carlyle Reports Fourth Quarter and Full-Year 2023 Financial Results
7 Feb 24
8-K
Departure of Directors or Certain Officers
18 Jan 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Carlyle Reports Third Quarter 2023 Financial Results
6 Nov 23
Transcripts
CG
Earnings call transcript
2023 Q4
7 Feb 24
CG
Earnings call transcript
2023 Q3
7 Nov 23
CG
Earnings call transcript
2023 Q2
2 Aug 23
CG
Earnings call transcript
2023 Q1
4 May 23
CG
Earnings call transcript
2022 Q4
7 Feb 23
CG
Earnings call transcript
2022 Q3
8 Nov 22
CG
Earnings call transcript
2022 Q2
28 Jul 22
CG
Earnings call transcript
2022 Q1
28 Apr 22
CG
Earnings call transcript
2021 Q4
3 Feb 22
CG
Earnings call transcript
2021 Q3
28 Oct 21
Latest ownership filings
4
CommScope Holding Company, Inc.
2 Apr 24
SC 13G
Q32 Bio Inc.
29 Mar 24
4
HARVEY M SCHWARTZ
5 Mar 24
SC 13D/A
Carlyle Group Management L.L.C.
5 Mar 24
4
HARVEY M SCHWARTZ
16 Feb 24
144
Notice of proposed sale of securities
15 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Jasper Therapeutics, Inc.
12 Feb 24
SC 13D/A
Jasper Therapeutics, Inc.
12 Feb 24
SC 13G/A
ZoomInfo Technologies Inc.
12 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.27 bn | 1.27 bn | 1.27 bn | 1.27 bn | 1.27 bn | 1.27 bn |
Cash burn (monthly) | (no burn) | 7.53 mm | (no burn) | (no burn) | (no burn) | 14.17 mm |
Cash used (since last report) | n/a | 51.47 mm | n/a | n/a | n/a | 96.90 mm |
Cash remaining | n/a | 1.22 bn | n/a | n/a | n/a | 1.18 bn |
Runway (months of cash) | n/a | 162.2 | n/a | n/a | n/a | 83.0 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 407 |
Opened positions | 53 |
Closed positions | 34 |
Increased positions | 141 |
Reduced positions | 134 |
13F shares | Current |
---|---|
Total value | 6.02 tn |
Total shares | 369.01 mm |
Total puts | 911.90 k |
Total calls | 2.09 mm |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Carlyle Group Management L.L.C. | 152.13 mm | $5.75 bn |
Vanguard | 23.12 mm | $697.30 bn |
BLK Blackrock | 21.69 mm | $654.17 bn |
Capital World Investors | 19.97 mm | $602.30 bn |
MS Morgan Stanley | 18.02 mm | $543.63 bn |
Mubadala Investment Co PJSC | 16.89 mm | $795.65 mm |
Alkeon Capital Management | 11.43 mm | $344.75 bn |
Vulcan Value Partners | 9.81 mm | $296.08 bn |
William Blair Investment Management | 8.88 mm | $267.74 bn |
Ariel Investments | 6.36 mm | $191.95 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 24 | Carlyle Group Inc | Series A Convertible Preferred Stock Common Stock | Other | Acquire J | Yes | No | 0 | 15,978 | 0.00 | 1,178,063 |
1 Mar 24 | Harvey M Schwartz | Common Stock | Grant | Acquire A | No | No | 0 | 50,131 | 0.00 | 7,549,528 |
14 Feb 24 | Harvey M Schwartz | Common Stock | Grant | Acquire A | No | No | 0 | 731,351 | 0.00 | 7,499,397 |
8 Feb 24 | Carlyle Group Inc | Voting Common Stock | Buy | Acquire P | Yes | No | 12.95 | 190,000 | 2.46 mm | 1,066,189 |
6 Feb 24 | Charles Elliott Jr. Andrews | Common Stock | Grant | Acquire A | No | No | 0 | 37,576 | 0.00 | 144,708 |
6 Feb 24 | Charles Elliott Jr. Andrews | Common Stock | Grant | Acquire A | No | No | 0 | 4,478 | 0.00 | 107,132 |
6 Feb 24 | Charles Elliott Jr. Andrews | Common Stock | Grant | Acquire A | No | No | 0 | 17,909 | 0.00 | 102,654 |
News
"Carlyle Founders Ordered To Face Lawsuit On $344M Payout" - Bloomberg Law
24 Apr 24
UBS Maintains Neutral on Carlyle Group, Raises Price Target to $50
12 Apr 24
Barclays Maintains Overweight on Carlyle Group, Raises Price Target to $56
8 Apr 24
(CG) - Analyzing Carlyle Group's Short Interest
5 Apr 24
Tian Tu Plunges Into The Red On Sagging Hong Kong Stock Market
3 Apr 24
Press releases
OHA is Administrative Agent & Lead Left Arranger for Acentra Health's Private Refinancing
15 Apr 24
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
11 Apr 24
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
26 Mar 24
BMO and Carlyle Partner to Launch a Private Equity Strategy for Canada
22 Mar 24
SER Welcomes New Investment from TA to Accelerate Growth
21 Mar 24